References
- Takahashi H, Ishii K, Kashiwagi N, et al. Clinical application of apparent diffusion coefficient mapping in voxel-based morphometry in the diagnosis of Alzheimer's disease. Clin Radiol. 2017;72(2):108–115.
- Ali N. 2015. Understanding Alzheimer’s: an introduction for patients and caregivers. Lanham (Maryland) Etc.: Rowman & Littlefield, Cop.
- Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage. 2000;11(6 Pt 1):805–821.
- Echávarri C, Aalten P, Uylings HBM, et al. Atrophy in the parahippocampal gyrus as an early biomarker of Alzheimer’s disease. Brain Struct Funct. 2011;215(3-4):265–271.
- Noggle CA, Dean RS. 2015. Neuropsychology of cortical dementias. New York: Springer.
- Petrovic P, Kalisch R, Singer T, et al. Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J Neurosci. 2008;28(26):6607–6615.
- Jiang F, Dricot L, Weber J, et al. Face categorization in visual scenes may start in a higher order area of the right fusiform gyrus: evidence from dynamic visual stimulation in neuroimaging. J Neurophysiol. 2011;106(5):2720–2736.
- Leśniak M, Soluch P, Stępień U, et al. Pure alexia after damage to the right fusiform gyrus in a right-handed male. Neurol Neurochir Pol. 2014;48(5):373–377.
- Mazurek MF, Beal MF, Bird ED, et al. Oxytocin in Alzheimer's disease: postmortem brain levels. Neurology. 1987;37(6):1001–1001.
- Szeto A, McCabe PM, Nation DA, et al. Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin. Psychosom Med. 2011;73(5):393–400.
- Ziegler TE. Measuring peripheral oxytocin and vasopressin in nonhuman primates. Am J Primatol. 2018;80(10):e22871.
- McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939–939.
- Wismer Fries AB, Ziegler TE, Kurian JR, et al. Early experience in humans is associated with changes in neuropeptides critical for regulating social behavior. Proc Natl Acad Sci USA. 2005;102(47):17237–17240.
- Light KC, Grewen KM, Amico JA. More frequent partner hugs and higher oxytocin levels are linked to lower blood pressure and heart rate in premenopausal women. Biol Psychol. 2005;69(1):5–21.
- Ishunina TA, Swaab DF. Neurohypophyseal peptides in aging and Alzheimer’s disease. Ageing Res Rev. 2002;1(3):537–558.
- Ramos Bernardes da Silva Filho S, Oliveira Barbosa JH, Rondinoni C, et al. Neuro-degeneration profile of Alzheimer's patients: a brain morphometry study. Neuroimage Clin. 2017;15:15–24.
- Kang DW, Lim HK, Joo S, et al. Differential associations between volumes of atrophic cortical brain regions and memory performances in early and late mild cognitive impairment. Front Aging Neurosci. 2019;11. DOI:10.3389/fnagi.2019.00245
- Du AT. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2001;71(4):441–447.
- Van Hoesen GW, Hyman BT, Damasio AR. Entorhinal cortex pathology in Alzheimer's disease. Hippocampus. 1991;1(1):1–8.
- Grundwald NJ, Benítez DP, Brunton PJ. Sex-dependent effects of prenatal stress on social memory in rats: a role for differential expression of central vasopressin-1a receptors. J Neuroendocrinol. 2016;28(4). DOI:10.1111/jne.12343
- Toga AW, Thompson PM. Mapping brain asymmetry. Nat Rev Neurosci. 2003;4(1):37–48. ).
- Barnes J, Scahill RI, Schott JM, et al. Does Alzheimer's disease affect hippocampal asymmetry? Evidence from a cross-sectional and longitudinal volumetric MRI study. Dement Geriatr Cogn Disord. 2005;19(5-6):338–344.
- Derflinger S, Sorg C, Gaser C, et al. Grey-matter atrophy in Alzheimer's disease is asymmetric but not lateralized. J Alzheimers Dis. 2011;25(2):347–357.
- Geroldi C, Laakso MP, DeCarli C, et al. Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study. J Neurol Neurosurg Psychiatry. 2000;68(1):93–96.
- Thompson PM, Moussai J, Zohoori S, et al. Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cereb Cortex. 1998;8(6):492–509.
- North WG, Harbaugh R, Reeder T. An evaluation of human neurophysin production in Alzheimer’s disease: preliminary observations. Neurobiol Aging. 1992;13(2):261–265.
- Kagerbauer SM, Debus JM, Martin J, et al. Absence of a diurnal rhythm of oxytocin and arginine-vasopressin in human cerebrospinal fluid, blood and saliva. Neuropeptides. 2019;78:101977.
- Ma QL, Harris-White ME, Ubeda OJ, et al. Evidence of abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models. J Neurochem. 2007; 103(4):1594–1607.
- Kida S. A functional role for CREB as a positive regulator of memory formation and LTP. Exp Neurobiol. 2012; 21(4):136–140.
- Teich AF, Nicholls RE, Puzzo D, et al. Synaptic therapy in Alzheimer's disease: a CREB-centric approach. Neurotherapeutics. 2015;12(1):29–41.
- Amidfar M, de Oliveira J, Kucharska E, et al. The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease. Life Sci. 2020;257:118020
- Takahashi J, Yamada D, Ueta Y, et al. Oxytocin reverses Aβ-induced impairment of hippocampal synaptic plasticity in mice. Biochem Biophys Res Commun. 2020;528(1):174–178.
- Donix M, Burggren AC, Scharf M, et al. APOE associated hemispheric asymmetry of entorhinal cortical thickness in aging and Alzheimer's disease. Psychiatry Res. 2013;214(3):212–220.